Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis BioCryst Pharmaceuticals Inc. BCRX

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedem...


Opinion & Analysis (NDAQ:BCRX)

The Calandra Report: Blood in streets, rivers of fortune

Thom Calandra July 24, 2015

The Calandra Report: Rapivab, MERS, Thailand & BCRX

Thom Calandra June 19, 2015

The Calandra Report: Show me a favorite, I dare you

Thom Calandra June 8, 2015

The Calandra Report: Moveable feast of pharma, not gold

Thom Calandra June 4, 2015

The Calandra Report: They're jamming In the name of the lode

Thom Calandra March 13, 2015

Ultra-Actionables: Natcore Tech, Angkor Gold, BioCryst, Vegas

Thom Calandra February 20, 2015

The Calandra Report: Author sees 10% death rattle for big stocks

Thom Calandra January 27, 2015

The Calandra Report: X-Factor stocks

Thom Calandra December 30, 2014

Thom's big stake In Cambodia gets bigger

Thom Calandra December 8, 2014

Le Plus TCR En Route: More On Way

Thom Calandra December 5, 2014

The Calandra Report: Thom teaches papaya, plus blazing coconuts, Gemma’s gems and Asia

Thom Calandra November 21, 2014

The Calandra Report: Food for thought... Biocryst, Sysorex

Thom Calandra November 6, 2014

The Calandra Report: Wild Cards, Breeders' Cup In California, Natcore, West Africa

Thom Calandra October 31, 2014

The Calandra Report: Roux New Orleans, parabola on our plates

Thom Calandra October 29, 2014

The Calandra Report: Top choices for fearless investors

Thom Calandra October 21, 2014

The Calandra Report: BioCryst Pharma, nothing to sneeze at

Thom Calandra October 15, 2014

The Calandra Report: Full Moon Promises A National Day For Global Resources

Thom Calandra October 8, 2014

The Calandra Report: The virus that is making resources bearable, just

Thom Calandra October 3, 2014

The Calandra Report: Pat’s Spectacular Now, Colt’s Crossroads

Thom Calandra September 29, 2014

The Calandra Report: Making BioCryst pay

Thom Calandra June 30, 2014